Harrow, Inc. Proceeds from Maturities, Prepayments and Calls of Short-term Investments
Harrow, Inc. (HROW) reported Proceeds from Maturities, Prepayments and Calls of Short-term Investments of -$100.00 thousand for the 6-month period ending 2014-06-30, per its 10-Q filed 2014-08-13.
Discontinued › Cash Flow › Investing Activities
us-gaap:ProceedsFromMaturitiesPrepaymentsAndCallsOfShorttermInvestments · last filed 2014-08-13
- Harrow, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2013-12-31 was $0.00.
- Harrow, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2013-09-30 was $0.00.
- Harrow, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2013-06-30 was $0.00.
- Harrow, Inc. proceeds from maturities, prepayments and calls of short-term investments for the quarter ending 2013-03-31 was -$50.00K.
- Harrow, Inc. proceeds from maturities, prepayments and calls of short-term investments for fiscal 2013 was -$50.00K.
| Period end | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 3 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 6 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 9 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 12 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 176 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 182 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 185 month | Proceeds from Maturities, Prepayments and Calls of Short-term Investments 188 month |
|---|---|---|---|---|---|---|---|---|
| 2014-06-30 | -$100.00K 10-Q · filed 2014-08-13 | |||||||
| 2014-03-31 | -$50.00K 10-Q · filed 2014-05-15 | |||||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-28 | $0.00 derived: sum of 2 quarters · filed 2014-03-28 | $0.00 derived: sum of 3 quarters · filed 2014-08-13 | -$50.00K 10-K · filed 2014-03-28 | -$50.00K 10-K · filed 2014-03-28 | |||
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $0.00 derived: sum of 2 quarters · filed 2014-08-13 | -$50.00K 10-Q · filed 2013-11-06 | -$50.00K 10-Q · filed 2013-11-06 | ||||
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-13 | -$50.00K 10-Q · filed 2014-08-13 | -$50.00K 10-Q · filed 2013-08-14 | |||||
| 2013-03-31 | -$50.00K 10-Q · filed 2014-05-15 | -$50.00K 10-Q · filed 2013-05-08 | ||||||
| 2012-03-31 | $0.00 10-Q · filed 2013-05-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Jaguar Health, Inc. (JAGX) | United States | $1.184B | |
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| Bicara Therapeutics Inc. (BCAX) | United States | $1.309B | -10.55 |
| Tyra Biosciences, Inc. (TYRA) | United States | $1.337B | -12.83 |
| Kardigan, Inc. (KARD) | United States | $1.346B |